🔎 Trials Near Me

Home › Osteosarcoma › Alabama

Pag-aaral pangklinika para sa Osteosarcoma sa Alabama

7 pag-aaral para sa Osteosarcoma ang naghahanap ng mga kalahok sa mga site sa Alabama.

Mga Lungsod sa Alabama

Opisyal na teksto ng pag-aaral (English)

Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid Tumors

  • University of Alabama/Children's of Alabama, Birmingham
Nagre-recruitPhase 1/2
Hanggang edad 30 · Lahat ng kasarian · Na-update Set 3, 2026 · NCT06541262

Eflornithine (DFMO) and AMXT 1501 for Neuroblastoma, CNS Tumors, and Sarcomas

  • University of Alabama/Children's of Alabama, Birmingham
Nagre-recruitPhase 1/2
Hanggang edad 26 · Lahat ng kasarian · Na-update Set 3, 2026 · NCT06465199

Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

  • Children's Hospital of Alabama, Birmingham
Nagre-recruitPhase 1/2
12 Months – 30 Years · Lahat ng kasarian · Na-update Ago 25, 2026 · NCT04851119

Thoracotomy Versus Thoracoscopic Management of Pulmonary Metastases in Patients With Osteosarcoma

  • Children's Hospital of Alabama, Birmingham
Nagre-recruitPhase 3
Hanggang edad 50 · Lahat ng kasarian · Na-update Ago 25, 2026 · NCT05235165

Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment

  • Children's Hospital of Alabama, Birmingham
Nagre-recruitObservasyonal na pag-aaral
Lahat ng edad · Lahat ng kasarian · Na-update May 18, 2026 · NCT01790152

Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer

  • University of Alabama at Birmingham, Birmingham
  • University of South Alabama, Mobile
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Abr 30, 2026 · NCT05297734

A Study of Cabozantinib as a Maintenance Agent to Prevent Progression or Recurrence in High-Risk Pediatric Solid Tumors

  • Children's Hospital of Alabama/UAB, Birmingham
Nagre-recruitPhase 2
18 Months – 40 Years · Lahat ng kasarian · Na-update Ago 12, 2025 · NCT05135975

Mula sa ClinicalTrials.gov, na-kuha noong Set 30, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.